pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·1h ago·1 min read
save

FDA says initial rejections of new drugs have declined

The FDA is looking to dispel what it says are inaccurate claims that it's increasingly rejecting new drugs after an initial review. The claims stem from a 2027 budget-related report from ...

Sep 18, 2026·read at Endpoints ↗

September 18, 2026 12:26 PM EDT PharmaFDA+ FDA says ini­tial re­jec­tions of new drugs have de­clined Zachary Brennan Senior Editor The FDA is look­ing to dis­pel what it says are in­ac­cu­rate claims that it’s in­creas­ing­ly re­ject­ing new drugs af­ter an ini­tial re­view. The claims stem … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
80 words · retrieved 2m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 41m agoCHMP backs Novo’s hemophilia A drug and seven other medicinesEndpoints
  • 2h agoChina sets ambitious goals for global biopharma expansion in new five-year planEndpoints
  • 2h agoAnthropic starts verification program for using Mythos in biologyEndpoints
  • 6h agoLegend names new CEO as Carvykti competition grows; Vertex makes a flurry of movesEndpoints
  • 16h agoElectra's $350M IPO will help it become a commercial biotechEndpoints